6 For Your Health 8/16/11

Cysview and Cancer Detection

Set Text Size SmallSet Text Size MediumSet Text Size LargeSet Text Size X-Large
Share
Updated: 8/16/2011 7:00 pm

In today's 6 For Your Health headlines... Doctors have a new way of detecting tiny bladder cancer tumors by making them glow. Chris Clackum has the details.

Even the trained eye can't see cancer is lurking, hidden in this bladder tissue. Until someone flips on the light. That bright pink is a tumor.

You're looking at new technology called "Cysview." It uses a combination of dye and fluorescent light to show surgeons small cancerous tumors that are undetectable using standard lights.

"You think everything's gone then you look there and say oh, it's not."

Dr. Stephen Jones of the Cleveland Clinic is one of a handful of urologists across the country using "Cysview."

Dr. Stephen Jones - urologist, Cleveland Clinic: "I could look and it appeared that everything was completely gone and in the past I would have finished up the operation and gone away."

About half of all bladder cancers recur after the first round of treatment whether it's surgery, chemo or both.

But Dr. Jones says it's likely that some of those recurrences are tumors that were missed during surgery. When they're finally found -- sometimes months or years later -- they're bigger and more aggressive.

Patient Mark Grilli had a recurrence of bladder cancer.

Mark Grilli - bladder cancer patient: "They actually found it was a higher grade, so now it spreads more quickly, and it grows more quickly. So they become a little more concerned."

Dr. Jones used the new technology during Grilli's second surgery and says his chances of having another recurrence are now slimmer.

Dr. Stephen Jones: "The likelihood of having a recurrence goes down by about 20% in the patients who undergo fluorescent cystoscopy."

The Food and Drug Administration approved Cysview last year. Studies to gauge its safety are ongoing, but doctors say they haven't seen any major complications.

Share
1 Comment(s)
Comments: Show | Hide

Here are the most recent story comments.View All

pinecrest - 8/23/2011 7:40 PM
0 Votes
This drug and diagnostic procedure has been available and in use in Europe since 2005, with the same success that is now being seen in the US. In 2009, the FDA put it on an "expedited" path for approval and that first step of approval was gained in January 2010. It is no wonder that bladder cancer is such an expensive disease to treat when patients have to undergo expensive diagnostic procedures every three months with no real assurance that tumors will be detected. Makes me wonder if the FDA procedures are really protecting me. And full implementation of the Affordable Health Care Act needs to happen as a first step in improving health care in the US. This country needs to do better and it can. M. Rogers
Elections



All content © Copyright 2011 Intermountain West Communications Company. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.
Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.